- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03710746
Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program (PH)
Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prevention is key for combating obesity, but few programs have prevented future increases in BMI and onset of overweight/obesity, particularly during late adolescence when youth often assume responsibility for dietary intake and exercise choices. One exception is a brief 6-hr dissonance-based program (Project Health) wherein participants make small lasting incremental lifestyle changes to dietary intake and exercise to reach energy balance, and discuss costs of obesity, an unhealthy diet, and sedentary behavior, and benefits of leanness, a healthy diet, and exercise, which prompts them to align their attitudes with their publicly displayed behavior. These activities promote the internalization of health goals and executive control over lifestyle behaviors. Late adolescents randomized to Project Health showed fewer increases in BMI and a 41% and 43% reduction in overweight/obesity onset over 2-yr follow-up compared to a version of the program lacking dissonance induction activities and an obesity education condition. Project Health appears to be the first program to produce these key obesity prevention effects relative to an alternative intervention, but it is critical to increase effects. A dissonance-based prevention program was more effective when implemented in single- versus mixed-sex groups, theoretically, because it promoted greater participation in dissonance-inducing discussions. Aim 1a is to test whether the weight gain prevention effects will be larger when Project Health is implemented in single-sex groups; the investigators will randomize 450 17-20-year-olds to complete Project Health in female, male, or mixed-sex groups, assessing outcomes at pretest, post-test, and 6, 12, 24, and 36-month follow-ups. Aim 1b is to test whether greater participation in dissonance-inducing discussions and group cohesion mediate the effect of condition on any superior weight gain prevention effects. Adolescents who show greater functional Magnetic Resonance Imaging( fMRI)-assessed reward and attention region responsivity to food images exhibit elevated future weight gain, implying that reducing this responsivity may reduce future weight gain. In a pilot trial, late adolescents who completed go/no-go, stop-signal, and respond-signal computer training in which they repeatedly inhibit responses to high-calorie foods and respond to low-calorie foods, and dot-probe and visual-search computer tasks that train attention away from high-calorie foods and to low-calorie foods, showed a greater reduction in reward and attention region responsivity to, palatability rating of, and willingness to pay for, high-calorie foods, suggesting reduced valuation and attentional bias, as well as greater fat loss over 1-yr follow-up versus controls who completed the training with non-food images. Aim 2a is to test whether adding food response and attention training to Project Health will produce larger weight gain prevention effects. Participants in the 3 conditions will be randomized to complete response and attention training for 25-mins after each of the 6-sessions with either food or non-food images. Aim 2b is to test whether reduced palatability ratings of, willingness to pay, and attentional bias for high-calorie foods mediate the effect of training condition on any superior weight gain prevention effects.
During the Coronavirus Disease 2019 (COVID-19) shelter-at-home order, the investigators will not measure in-person only outcomes including assessments using the BodPod (a body composition tracking system using air displacement plethysmography), and height and weight measurement for BMI calculation for all participants that have assessments due during this order. The investigators will continue to conduct intervention groups that will be administered on a virtual platform.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Eugene, Oregon, United States, 97403
- Oregon Research Institute
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Drexel University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Current at least moderate weight concerns (response of moderate, severe or extreme to the presence of weight concerns question)
- BMI between 20 and 30
Exclusion Criteria:
- Current diagnosis of anorexia nervosa, bulimia nervosa, or binge eating disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mixed Group, Food Response Training
Participants in this arm will be assigned to receive Project Health in mixed-sex groups and will complete the food-focused response and attention training intervention.
|
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
|
|
Experimental: Mixed Group, Generic Response Training
Participants in this arm will be assigned to receive Project Health in mixed-sex groups and will complete the generic response and attention training intervention.
|
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
|
|
Experimental: Female Group, Food Response Training
Participants in this arm will be assigned to receive Project Health in female-only groups and will complete the food-focused response and attention training intervention.
|
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
|
|
Experimental: Female Group, Generic Response Training
Participants in this arm will be assigned to receive Project Health in female-only groups and will complete the generic response and attention training intervention.
|
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
|
|
Experimental: Male Group, Food Response Training
Participants in this arm will be assigned to receive Project Health in male-only groups and will complete the food-focused response and attention training intervention.
|
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
|
|
Experimental: Male Group, Generic Response Training
Participants in this arm will be assigned to receive Project Health in male-only groups and will complete the generic response and attention training intervention.
|
A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.
Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Fat
Time Frame: Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
|
Change in percentage of body fat (Not collected during COVID-19 shelter-at-home order)
|
Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Concerns Scale from the Eating Disorder Examination Questionnaire (EDE-Q)
Time Frame: Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
|
Change in weight concerns.
Scale scores range from 0 to 42 with higher scores being indicative of higher weight concerns.
|
Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
|
|
Beck Depression Index (BDI)
Time Frame: Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
|
Change in depressive symptoms
|
Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
|
|
Eating Disorder Interview (EDDI)
Time Frame: Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
|
Change in eating disorder symptoms
|
Baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Eric M Stice, Ph.D., Oregon Research Institute
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HD093598-01A1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
PfizerRecruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Massachusetts General HospitalDenver Health and Hospital Authority; Prisma Health-UpstateCompletedOverweight and Obesity | Severe ObesityUnited States
-
Mexican National Institute of Public HealthUNICEFCompleted
Clinical Trials on Project Health
-
University of Illinois at ChicagoTerminated
-
Hunter College of City University of New YorkNational Institute on Drug Abuse (NIDA)RecruitingHIV Infections | Substance UseUnited States
-
Nova Southeastern UniversityJohn H. Stroger HospitalCompletedRisk Reduction | Unsafe SexUnited States
-
Rhode Island HospitalCompletedAdolescent Dating ViolenceUnited States
-
University of HoustonRecruiting
-
Hunter College of City University of New YorkNational Institute on Drug Abuse (NIDA)CompletedRisk Behavior | Drug Use | Sex, AnalUnited States
-
Kaiser PermanenteWithdrawnType 2 DiabetesUnited States
-
Gadjah Mada UniversityPfizer; Queensland University of TechnologyNot yet recruitingCancer | Metastatic Breast CancerIndonesia
-
Oregon Research InstituteCompletedObesity | Weight Gain | Eating DisordersUnited States
-
University of RochesterNational Cancer Institute (NCI); National Institutes of Health (NIH); New York... and other collaboratorsCompletedTobacco Use DisorderUnited States